Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone patches can modestly improve sexual function in postmenopausal women not on estrogen therapy.

Oophorectomy lowers testosterone and estrogen levels in both premenopausal and postmenopausal women, with postmenopausal women still producing significant testosterone.

A postmenopausal woman's excessive hair growth and hair loss were due to a non-cancerous ovarian condition, treated successfully with surgery.

Most postmenopausal women experience significant skin changes and various skin conditions.

Hormone replacement therapy may improve hair growth in the frontal hairline of postmenopausal women with hair loss.

Topical estrogen helps hair growth in menopausal women with no major side effects.

17α-estradiol is a safe estrogen that might protect the brain and doesn't cause feminization, needing more research for treating brain diseases.

Genetics, low estrogen, and low iron levels contribute to female hair loss, with specific scalp signs indicating severity.

Ovariectomized mice mimic postmenopausal hair loss, and estradiol helps maintain hair density.

Frontal fibrosing alopecia mainly affects postmenopausal women and may be linked to thyroid hormones.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

Formestane is a preferred second-line treatment for advanced breast cancer in postmenopausal women because it's effective and has fewer side effects.

Hormone therapy might help improve women's appearance as they age.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Doctors recommend postoperative radiation for male breast cancer, advise against testosterone for vasomotor symptoms post-adrenalectomy, suggest non-hormonal treatments for atrophic vaginitis after mastectomy, note no specific treatment for anticoagulant-induced hair loss, and call for more research on silicosis from silicon carbide exposure.

Red clover extract improved hair, skin, mood, sleep, and tiredness in postmenopausal women.

An 84-year-old woman's hair loss was due to a rare condition called Leydig cell hyperplasia, which was treated with surgery.

Injecting 2 ml of TEEV every 4 weeks is better because it has the same benefits but fewer side effects.

Some postmenopausal women with frontal fibrosing alopecia stopped losing hair with finasteride treatment, hinting at a possible hormonal cause.

Taking DHEA for a year is generally safe for postmenopausal women but may cause acne and more facial hair without improving metabolism or aging.

Researchers had trouble finding enough participants for a trial on DHEA's effects on postmenopausal women's sexual desire.

Benign ovarian tumors can cause excess male hormones and related conditions in postmenopausal women.

A thorough diagnostic process and teamwork are crucial for managing complex hyperandrogenism in postmenopausal women.

Postmenopausal ovary stromal cells have a unique makeup and limited steroid production, suggesting androgens come from the adrenal gland.

A postmenopausal woman's hirsutism and high testosterone levels improved after surgery for an ovarian tumor not seen on ultrasound.

The research found that MRI and certain hormone levels can help tell apart ovarian tumors from hyperthecosis in postmenopausal women, but tissue analysis is still needed for a definite diagnosis.

Hair loss in postmenopausal woman caused by ovarian issue.

Alopecia patients have less GPER-1, which might affect hair loss.

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

A woman's male-like symptoms and high testosterone were due to ovarian hilus-cell hyperplasia, which improved after surgery.